Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Abdallah Damin Abukhalil, Tala Al Sheikh, Sandra Muallem, Ni’meh Al-Shami & Hani A Naseef. (2023) Prevalence and Safety of Prescribing PPIs with Clopidogrel in Palestine. Patient Preference and Adherence 17, pages 749-759.
Read now
Read now
Goutham Yerrakula, Shyno Abraham, Shiji John, Mehrukh Zeharvi, Samuel Gideon George, V. Senthil, Fathi Maiz & Md. Habibur Rahman. (2022) Major implications of single nucleotide polymorphisms in human carboxylesterase 1 on substrate bioavailability. Biotechnology and Genetic Engineering Reviews 0:0, pages 1-19.
Read now
Read now
Renu Singh, Tanvi Naik, Anuja Nigam, Sagnik Chatterjee, Prabhakar Rajanna, Hong Shen & Ramaswamy Iyer. (2020) Is aspirin a substrate of MDR1/P-glycoprotein?. Xenobiotica 50:10, pages 1258-1264.
Read now
Read now
Margarita N Dorofeeva, Evgenia V Shikh, Zhanna M Sizova, Alisa V Tarasenko, Natalia P Denisenko, Valeriy V Smirnov, Kristina A Ryzhikova, Zhannet A Sozaeva, Elena A Grishina & Dmitriy A Sychev. (2019) Antihypertensive Effect Of Amlodipine In Co-Administration With Omeprazole In Patients With Hypertension And Acid-Related Disorders: Cytochrome P450-Associated Aspects. Pharmacogenomics and Personalized Medicine 12, pages 329-339.
Read now
Read now
Christian Höcht, Facundo M. Bertera, Yanina Santander Plantamura, Luciano Parola, Julieta S. Del Mauro & Ariel H. Polizio. (2019) Factors influencing hepatic metabolism of antihypertensive drugs: impact on clinical response. Expert Opinion on Drug Metabolism & Toxicology 15:1, pages 1-13.
Read now
Read now
Michał J Kubisa, Mateusz P Jezewski, Aleksandra Gasecka, Jolanta M Siller-Matula & Marek Postuła. (2018) Ticagrelor – toward more efficient platelet inhibition and beyond. Therapeutics and Clinical Risk Management 14, pages 129-140.
Read now
Read now
Lu Liu, Sen Sun, Hongbing Rui & Xiaohua Li. (2017) In vitro inhibitory effects of dihydromyricetin on human liver cytochrome P450 enzymes. Pharmaceutical Biology 55:1, pages 1868-1874.
Read now
Read now
Meng Chen & Quan Zhou. (2016) The use of oral suspension and rationally prescribing alternatives may be supplemental to the implementation of clopidogrel new algorithm comprising CYP2C19 pharmacogenetics and drug interactions. Therapeutics and Clinical Risk Management 12, pages 351-352.
Read now
Read now
Articles from other publishers (21)
Yani Wang, Yingrui Liu, Hongwei Yao, Xue Chen, Yantong Sun & Yingjie Guo. (2023) Decreased plasma exposure of clopidogrel active metabolite in rats after long‐term treatment with clopidogrel. Biopharmaceutics & Drug Disposition 44:2, pages 129-136.
Crossref
Crossref
Krupa A. Patel, Masumi H. Bhatt, Rajvi V. Hirani, Vidheesha A. Patel, Vishvas N. Patel, Gaurang B. Shah & Mehul R. Chorawala. (2022) Assessment of potential drug–drug interactions among outpatients in a tertiary care hospital: focusing on the role of P-glycoprotein and CYP3A4 (retrospective observational study). Heliyon 8:11, pages e11278.
Crossref
Crossref
Dayong Zheng, Xiao Li, Yang Chu, Yazhuo Li, Dekun Li, Aichun Ju, Yi Wu, Yuesheng Xie & Wei Li. (2022) Interaction study of salvianolic acids for injection on pharmacokinetics of clopidogrel in rats using LC–MS/MS. Biomedical Chromatography 36:11.
Crossref
Crossref
Xueyao Jiang, Jing Wu, Boyu Tan, Sulan Yan, Nan Deng & Hongyan Wei. (2022) Effect of chronic unpredicted mild stress-induced depression on clopidogrel pharmacokinetics in rats. PeerJ 10, pages e14111.
Crossref
Crossref
An V. Tran, Diem T. Nguyen, Son K. Tran, Trang H. Vo, Kien T. Nguyen, Phuong M. Nguyen, Suol T. Pham, Chu X. Duong, Bao L.T. Tran, Lien N.T. Tran, Han G. Diep, Minh V. Huynh, Thao H. Nguyen, Katja Taxis, Khanh D. Dang & Thang Nguyen. 2022. Coronary Artery Bypass Grafting. Coronary Artery Bypass Grafting.
Mei Zhao, Chuan-Fen Liu, Yu-Fei Feng & Hong Chen. (2022) Potential drug-drug interactions in drug therapy for older adults with chronic coronary syndrome at hospital discharge: A real-world study. Frontiers in Pharmacology 13.
Crossref
Crossref
Brent Ruiz, Karina G Romo, Jeremy Teruel, Jared Dendy & Qasim Z Iqbal. (2022) A Case of Hypoglycemia With Concomitant Use of a Sulfonylurea and Clopidogrel. Cureus.
Crossref
Crossref
In Hwan Lim, Seung Jae Lee, Byoung-Soo Shin & Hyun Goo Kang. (2022) Ilaprazole and Clopidogrel Resistance in Acute Stroke Patients. Biomedicines 10:6, pages 1366.
Crossref
Crossref
Antoine El Khoury, Zela Maria Butchakdjian, Elham Lagha, Peter Semaan & Maroun Soueidy. (2022) Acute Multiple In-Stent Thromboses in a Patient With Clopidogrel-Fluconazole Interaction. Cureus.
Crossref
Crossref
O. D. Lopina, B. K. Nurgalieva & T. L. Lapina. (2021) Current Trends in Treatment for Acid-Dependent Diseases: Clinical Efficacy and Safety of Rabeprazole. Russian Journal of Gastroenterology, Hepatology, Coloproctology 31:4, pages 55-63.
Crossref
Crossref
Joachim Andreas Koeck, Heike Hilgarth, Andreas von Ameln-Mayerhofer, Damaris Meyn, Ruediger Warlich, Andreas Münstedt, Dagmar Horn & Christina König. (2021) Clinically Relevant Interactions with Anti-Infectives on Intensive Care Units—A Multicenter Delphi Study. Antibiotics 10:11, pages 1330.
Crossref
Crossref
Chen Ning, Shengdi Su, Jiaming Li, Dexuan Kong, Hui Cai, Zhiying Qin, Han Xing, Xijing Chen & Jiake He. (2021) Evaluation of a Clinically Relevant Drug–Drug Interaction Between Rosuvastatin and Clopidogrel and the Risk of Hepatotoxicity. Frontiers in Pharmacology 12.
Crossref
Crossref
Jennifer Lagoutte-Renosi, Bernard Royer, Vahideh Rabani & Siamak Davani. (2021) Validation of an HPLC–MS/MS Method for the Determination of Plasma Ticagrelor and Its Active Metabolite Useful for Research and Clinical Practice. Molecules 26:2, pages 278.
Crossref
Crossref
Dejan AleksićZ.Z., Srđan StefanovićM.M., Miloš MilosavljevićN.N., Jovana MilosavljevićZ.Z. & Slobodan JankovićM.M.. (2021) Frequency and predictors of potential drug: Drug interactions in hospitalized patients with Parkinson's diseases. Hospital Pharmacology - International Multidisciplinary Journal 8:3, pages 1099-1108.
Crossref
Crossref
Tuire Prami, Houssem Khanfir, Pål Hasvold, Eeva Reissell, Juhani Airaksinen & Ville Kytö. (2019) Concomitant use of drugs known to cause interactions with oral antiplatelets—polypharmacy in acute coronary syndrome outpatients in Finland. European Journal of Clinical Pharmacology 76:2, pages 257-265.
Crossref
Crossref
Dmitry A. Sychev, Igor N. Sychev, Karin B. Mirzaev, Eric I. Rytkin, Dmitriy V. Ivashchenko, Irina V. Bure & Vitaliy A. Otdelenov. (2019) Clinical pharmacology technologies for personalization of cardiovascular diseases drug treatment: focus on direct oral anticoagulants. Annals of the Russian academy of medical sciences 74:5, pages 299-306.
Crossref
Crossref
E I Rytkin, K B Mirzaev, I V Bure & D A Sychev. (2019) Micro-RNA as a new biomarker of activity of the cytochrome system P-450: significance for predicting the antiplatelet action of P2Y12 receptor inhibitors. Terapevticheskii arkhiv 91:8, pages 115-117.
Crossref
Crossref
Jose J. Lopez, Mohammed El Haouari, Isaac Jardin, Nieves Alonso, Sergio Regodon, Raquel Diez-Bello, Pedro C. Redondo & Juan A. Rosado. (2019) Flavonoids and Platelet-Derived Thrombotic Disorders. Current Medicinal Chemistry 26:39, pages 7035-7047.
Crossref
Crossref
Carlos Moya & Salvador Máñez. (2018) Paraoxonases: metabolic role and pharmacological projection. Naunyn-Schmiedeberg's Archives of Pharmacology 391:4, pages 349-359.
Crossref
Crossref
Guangwen Luo, Yiting Shen, Lizhu Yang, Aiping Lu & Zheng Xiang. (2017) A review of drug-induced liver injury databases. Archives of Toxicology 91:9, pages 3039-3049.
Crossref
Crossref
Wengen Zhu & Kui Hong. (2017) Potential Cardiovascular Risks of Proton Pump Inhibitors in the General Population. International Heart Journal 58:2, pages 163-166.
Crossref
Crossref